the carlyle group - Search News

bluebird bio sells itself to Carlyle, SK Capital

Bluebird Bio to Be Acquired by Carlyle Group, SK Capital

Cash-strapped gene-therapy company Bluebird bio agreed to be acquired by private-equity firms Carlyle Group and SK Capital Partners in a deal potentially worth up to $96 million.

Seeking Alpha on MSN · 2d

bluebird bio plunges after take-private deal with Carlyle and SK Capital

(NASDAQ:BLUE) lost ~37% in the premarket on Friday after the gene therapy developer announced its plans to become a privately held biotech as part of an M&A agreement with private equity firms Carlyle Group (NASDAQ:CG) and SK Capital Partners.

Reuters on MSN · 1d

Gene therapy maker bluebird to go private in discounted deal amid cash crunch

By Sneha S K (Reuters) -Gene therapy maker bluebird bio on Friday agreed to be taken private by Carlyle Group and SK Capital Partners at a discount, after a prolonged struggle to survive a cash crunch due to a difficult market environment for gene therapies.

The Carlyle Group (NASDAQ:CG) Cut to Sell at StockNews.com

The Carlyle Group (NASDAQ:CG – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” ...

Morningstar10d

The Carlyle Group Inc

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

10d

Carlyle Group Enters Indian Auto Parts Industry With Highway-Roop Platform Buy

(Reuters) - U.S.-based investment firm Carlyle Group has entered India's auto components market by buying a controlling stake ...

New York State Teachers Retirement System Sells 300 Shares of The Carlyle Group Inc. (NASDAQ:CG)

New York State Teachers Retirement System trimmed its position in The Carlyle Group Inc. (NASDAQ:CG – Free Report) by 0.7% during the 4th quarter, HoldingsChannel reports. The firm owned 44,246 shares ...

Carlyle price target lowered to $47 from $50 at BofA

BofA analyst Craig Siegenthaler lowered the firm’s price target on Carlyle (CG) to $47 from $50 and keeps an Underperform rating on the shares ...

secondariesinvestor11d

Carlyle’s AlpInvest nears target for eighth flagship

AlpInvest Secondaries Fund VIII has raised nearly $9.4 billion as of 31 December 2024, according to materials prepared for ...

India's Carlyle-backed IT exporter Hexaware valued at $5 bln in solid debut

Shares of Carlyle-backed Hexaware Technologies rose as much as 10% in their debut on Wednesday, indicating rising retail interest in India's first billion-dollar IPO that struggled to achieve full ...

Carlyle Group (CG) Receives a Rating Update from a Top Analyst

Bank of America Securities analyst Craig Siegenthaler maintained a Sell rating on Carlyle Group (CG – Research Report) yesterday and set a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results